These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9519369)

  • 1. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
    Radmayr C; Culig Z; Hobisch A; Corvin S; Bartsch G; Klocker H
    Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.
    Radmayr C; Culig Z; Glatzl J; Neuschmid-Kaspar F; Bartsch G; Klocker H
    J Urol; 1997 Oct; 158(4):1553-6. PubMed ID: 9302173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor.
    Pinsky L; Kaufman M; Killinger DW; Burko B; Shatz D; Volpé R
    Am J Hum Genet; 1984 Sep; 36(5):965-78. PubMed ID: 6333813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia.
    Kaspar F; Cato AC; Denninger A; Eberle J; Radmayr C; Glatzl J; Bartsch G; Klocker H
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):127-35. PubMed ID: 8274427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete androgen insensitivity syndrome: partially masculinized genitalia in two patients with absence of androgen receptor in cultured fibroblasts.
    Sultan C; Picard JY; Josso N; Migeon CJ
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):565-74. PubMed ID: 6640957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor.
    Brown TR; Maes M; Rothwell SW; Migeon CJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):61-9. PubMed ID: 7076808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An androgen receptor mutation causing androgen resistance in undervirilized male syndrome.
    Tsukada T; Inoue M; Tachibana S; Nakai Y; Takebe H
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1202-7. PubMed ID: 7962294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.
    Tincello DG; Saunders PT; Hodgins MB; Simpson NB; Edwards CR; Hargreaves TB; Wu FC
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
    Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial incomplete male pseudohermaphroditism associated with impaired nuclear androgen retention. Studies in cultured skin fibroblasts.
    Eil C
    J Clin Invest; 1983 Apr; 71(4):850-8. PubMed ID: 6833492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen insensitivity syndrome.
    Mendoza N; Motos MA
    Gynecol Endocrinol; 2013 Jan; 29(1):1-5. PubMed ID: 22812659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.